Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity
Joseph W. Watkins
, Evan S. Schwarz
, Anna M. Arroyo-Plasencia
,
Michael E. Mullins
Department of Emergency Medicine
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Contribution to journal
›
Article
›
peer-review
50
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Physostigmine
100%
Toxicologist
100%
Cholinergic Toxicity
100%
Benzodiazepines
45%
Anticholinergic Toxidrome
27%
Definitive Treatment
18%
Antipsychotics
18%
Intubation
18%
Toxidrome
18%
Treatment Group
9%
Low Dose Rate
9%
Consecutive Patients
9%
Causative Agents
9%
Toxicology
9%
Liberal
9%
Multiple Actions
9%
Rate-based
9%
Medical Toxicologists
9%
Causal Agent
9%
Controversy Studies
9%
Pharmacology, Toxicology and Pharmaceutical Science
Physostigmine
100%
Cholinergic Receptor Blocking Agent
100%
Toxidrome
45%
Intubation
18%
Toxicology
9%
Treatment Group
9%